Immunogenicity of Bivalent HPV Vaccine Among Partially Vaccinated Young Adolescent Girls in Uganda
This article, published in Vaccine, reports on a study on the immunogenicity of bivalent human papillomavirus (HPV) vaccine among adolescent girls from Uganda who received one, two, or three vaccine doses. The authors found that even though immunogenicity with less than three doses did not meet a priori non-inferiority thresholds, antibody levels measured more than 24 months after the last dose were similar to those of adult women who have been followed for more than eight years. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author: LaMontagne DS, Mugisha E, Pan Y, et al.
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: LaMontagne DS, Mugisha E, Pan Y, et al. Immunogenicity of Bivalent HPV Vaccine Among Partially Vaccinated Young Adolescent Girls in Uganda. Vaccine. 2014;32(47):6303-6311.
Resource types: Peer-reviewed journal
Diseases/vaccines: Human papillomavirus (HPV)